The ying and yang of idebenone: Not too little, not too much – cell death in NQO1 deficient cells and the mouse retina-Reference-Cited by-同舟云学术

The ying and yang of idebenone: Not too little, not too much – cell death in NQO1 deficient cells and the mouse retina

Published:2020-05 Issue: Volume:152 Page:551-560
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Varricchio C.,Beirne K.,Heard C.,Newland B.,Rozanowska M.,Brancale A.,Votruba M.

Funder

Welsh Government

Life Sciences Research Network Wales scheme

National Eye Research Centre

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference38 articles.

1. Efficacy and safety of idebenone in the long-term treatment of Alzheimer's disease: a double blind, placebo controlled multicentre study;Weyer;Hum. Psychopharmacol. Clin. Exp.,1996

2. Neuromuscular disorders idebenone as a novel therapeutic approach for Duchenne muscular dystrophy neuromuscular disorders;Rocha;Am. J. Hypertens.,2015

3. Idebenone: a review in Leber's hereditary optic neuropathy;Lyseng-Williamson;Drugs,2016

4. Idebenone in Friedreich ataxia and Leber's hereditary optic neuropathy: close mechanisms, similar therapy?;Schiff;Brain,2016

5. Discovery of ubiquinone (coenzyme Q) and an overview of function;Crane;Mitochondrion,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC25A19 is required for NADH homeostasis and mitochondrial respiration;Free Radical Biology and Medicine;2024-09

2. Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management;Progress in Retinal and Eye Research;2024-07

3. The role of the methoxy group in approved drugs;European Journal of Medicinal Chemistry;2024-07

4. Idebenone Antagonizes P53-Mediated Neuronal Oxidative Stress Injury by Regulating CD38-SIRT3 Protein Level;Neurochemical Research;2024-06-12

5. Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial;Cell Reports Medicine;2024-03